The Ras/Raf/MAPK Pathway
Julian R. Molina, Alex A. Adjei · Journal of Thoracic Oncology · 2006
Cited by 324 works. doi:10.1016/s1556-0864(15)31506-9 Open-access PDF
Authors
References
- Mutations of the BRAF gene in human cancer
- ras GENES
- Cell Signaling by Receptor Tyrosine Kinases
- Cell Signaling by Receptor Tyrosine Kinases
- Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib
- Ras recruits Raf‐1 to the plasma membrane for activation by tyrosine phosphorylation.
- Ras Activation of the Raf Kinase: Tyrosine Kinase Recruitment of the MAP Kinase Cascade
- Blocking Oncogenic Ras Signaling for Cancer Therapy
- The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis
- Implications and Prognostic Value of K-ras Mutation for Early-Stage Lung Cancer in Women